HCA Holdings Inc. (NYSE:HCA) was downgraded by Mizuho from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday.

Several other research firms have also recently commented on HCA. Jefferies Group reaffirmed a “buy” rating on shares of HCA Holdings in a report on Wednesday, August 10th. Credit Suisse Group AG reissued a “buy” rating and set a $87.00 target price on shares of HCA Holdings in a research note on Friday, July 29th. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, October 25th. KeyCorp raised HCA Holdings from a “sector weight” rating to an “overweight” rating and set a $94.00 target price for the company in a research note on Thursday, October 13th. Finally, Citigroup Inc. cut their target price on HCA Holdings from $86.00 to $85.00 and set a “neutral” rating for the company in a research note on Friday, July 29th. Nine research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $87.80.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Shares of HCA Holdings (NYSE:HCA) opened at 72.06 on Wednesday. The stock has a 50 day moving average price of $77.15 and a 200-day moving average price of $77.48. The stock has a market cap of $27.00 billion, a P/E ratio of 11.41 and a beta of 0.79. HCA Holdings has a 52 week low of $60.07 and a 52 week high of $83.69.

HCA Holdings (NYSE:HCA) last posted its quarterly earnings results on Thursday, October 27th. The company reported $1.61 EPS for the quarter, beating the consensus estimate of $1.42 by $0.19. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. The firm earned $10.27 billion during the quarter, compared to analysts’ expectations of $10.41 billion. During the same quarter last year, the firm earned $1.17 earnings per share. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. Equities analysts predict that HCA Holdings will post $6.72 EPS for the current fiscal year.

In other news, insider A Bruce Moore, Jr. sold 167,967 shares of the firm’s stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $73.65, for a total transaction of $12,370,769.55. Following the completion of the transaction, the insider now directly owns 207,682 shares in the company, valued at $15,295,779.30. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP P. Martin Paslick sold 36,004 shares of the firm’s stock in a transaction on Friday, October 28th. The stock was sold at an average price of $78.79, for a total value of $2,836,755.16. Following the transaction, the senior vice president now owns 35,894 shares of the company’s stock, valued at $2,828,088.26. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citizens Financial Group Inc RI raised its position in HCA Holdings by 0.6% in the third quarter. Citizens Financial Group Inc RI now owns 89,664 shares of the company’s stock valued at $6,782,000 after buying an additional 516 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of HCA Holdings by 16.4% in the third quarter. Nomura Asset Management Co. Ltd. now owns 61,271 shares of the company’s stock valued at $4,634,000 after buying an additional 8,655 shares during the period. Convergence Investment Partners LLC purchased a new position in shares of HCA Holdings during the third quarter valued at approximately $1,183,000. BOKF NA increased its position in shares of HCA Holdings by 90.7% in the third quarter. BOKF NA now owns 8,564 shares of the company’s stock valued at $648,000 after buying an additional 4,072 shares during the period. Finally, Morgan Stanley increased its position in shares of HCA Holdings by 2.4% in the third quarter. Morgan Stanley now owns 1,374,592 shares of the company’s stock valued at $103,959,000 after buying an additional 32,213 shares during the period. Institutional investors and hedge funds own 72.98% of the company’s stock.

HCA Holdings Company Profile

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.